Moderna Rg
MRNA
USD
STOCK MARKET:
NMS
Open
 
...
Delayed quote
Last quote
04/18/2024 - 13:25:36
Bid
04/18/2024 - 13:26:33
Bid
Volume
Ask
04/18/2024 - 13:26:33
Ask
Volume
102.24
-1.20 ( -1.16% )
102.14
100
102.31
400
More information
Analysis by TheScreener
16.04.2024
Evaluation Neutral  
Interest Weak  
Sensibility Middle  
Analysis date: 16.04.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 16.04.2024.
Interest
  Weak
Weak interest since 16.04.2024.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 12.04.2024 at a price of 105.14.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 23.02.2024), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 101.114.
4wk Rel Perf
  1.45%
 
The four week relative overperformance versus SP500 is 1.45%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 02.01.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.59%.
Mkt Cap in $bn
  39.77
With a market capitalization >$8bn, MODERNA is considered a large-cap stock.
G/PE Ratio
  -0.01
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -40.18
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -0.31%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  20
Over the last seven weeks, an average of 20 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  111
For 1% of index variation, the stock varies on average by 1.11%.
Correlation
  0.29
Stock movements are strongly independent of index variations.
Value at Risk
  24.91
The value at risk is estimated at USD 24.91. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  29.03.2019